Asean Health Screening Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
 Período de previsão |
2024 –2031 |
 Tamanho do mercado (ano base ) | USD 17,697.22 Million |
 Tamanho do mercado ( Ano de previsão) | USD 47,078.82 Million |
 CAGR |
% |
| Principais participantes do mercado |
>Mercado de rastreio de saúde da ASEAN , por tipo de teste (testes de colesterol, teste de diabetes, testes de cancro, teste de check-up geral, DST’s, teste de pressão arterial e outros), aplicação (doenças cardiovasculares, distúrbios metabólicos , oncologia, condições inflamatórias, distúrbios músculo-esqueléticos, neurológicos Condições, Complicações da Hepatite C, Condições Relacionadas com a Imunologia e Outras), Tipo de Painel (Painéis Multi-Testes, Painéis de Teste Único), Cuidados/Instalações (Integrado, Autónomo), Utilizador ( Utente Doméstico, Turista Médico), Rendimento do Cliente (Classe Alta, Classe Média e Classe Baixa), Fornecedor (Hospitais, Clínicas, Instalações de Enfermagem, Centros de Reabilitação, Laboratórios de Diagnóstico e Outros), Países (Índia, Singapura, Tailândia, Malásia, Indonésia, Filipinas, Vietname, Cambodja, Brunei , Birmânia e Laos) - Tendências e previsões da indústria para 2031.
Análise e insights do mercado de rastreio de saúde da ASEAN
Em outubro de 2023, de acordo com o evento denominado “Dia Internacional dos Idosos na Ásia e no Pacífico, 2023” publicado na Comissão Económica e Social para a Ásia e a região do Pacífico. Em 2023, estima-se que 697 milhões de pessoas idosas (60 anos ou mais) residam na Ásia e no Pacífico, representando cerca de 60 por cento de todas as pessoas idosas no mundo. Aproximadamente uma em cada 7 pessoas na região tem atualmente 60 anos ou mais e, em 2050, haverá uma em cada 4 pessoas pertencentes a esta faixa etária. As mulheres representam cerca de 54 por cento do total das mulheres idosas. Com o aumento da idade, a sua participação aumenta. Assim, as mulheres representam a maior parte das pessoas idosas da região. O envelhecimento da população na Ásia e no Pacífico é particularmente rápido, dado o declínio da fecundidade e da mortalidade nos últimos anos. Isto traduz-se num tempo limitado para se preparar para os impactos do envelhecimento nas sociedades.
A Data Bridge Market Research analisa que o mercado de exames de saúde da Asean deverá atingir os 47.078,82 milhões de dólares até 2031, face aos 17.697,22 milhões de dólares em 2023, crescendo a um CAGR de 13,5% no período de previsão de 2024 a 2031.
|
Métrica de reporte |
Detalhes |
|
Período de previsão |
2024 a 2031 |
|
Ano base |
2023 |
|
Anos históricos |
2022 (personalizável para 2016–2021) |
|
Unidades Quantitativas |
Receita em milhões de dólares |
|
Segmentos cobertos |
Tipo de teste (testes de colesterol, teste de diabetes , testes de cancro, teste de check-up geral, DSTs, teste de pressão arterial e outros), aplicação ( doenças cardiovasculares , distúrbios metabólicos, oncologia, condições inflamatórias, distúrbios musculoesqueléticos, condições neurológicas, complicações da hepatite C , Condições Relacionadas com Imunologia e Outras), Tipo de Painel (Painéis Multi-Testes, Painéis de Teste Único), Cuidados/Instalações (Integrado, Autónomo), Utente (Utilizador Doméstico, Turista Médico), Rendimento do Cliente (Classe Alta, Classe Média , e classe baixa), prestador (hospitais, clínicas, instalações de enfermagem, centros de reabilitação, laboratórios de diagnóstico e outros), países (Índia, Singapura, Tailândia, Malásia, Indonésia, Filipinas, Vietname, Camboja, Brunei, Birmânia e Laos) |
|
Países abrangidos |
Índia, Singapura, Tailândia, Malásia, Indonésia, Filipinas, Vietname, Cambodja, Brunei, Birmânia e Laos |
|
Participantes do mercado abrangidos |
Fullerton Health Corporation Limited, Hospital Mount Alvernia, PT Prodia Widyahusada Tbk, Raffles Medical Group e Icon Group, entre outros |
Definição de mercado
O rastreio de saúde é uma ferramenta importante para detetar uma doença precocemente. Os testes de rastreio são frequentemente utilizados na medicina preventiva para determinar se uma pessoa apresenta indicadores precoces dos fatores de risco de uma doença. Cancro, diabetes, colesterol elevado, hipertensão arterial e osteoporose são doenças que podem ser descobertas através de exames.
Este mercado abrange uma vasta gama de atividades, incluindo exames de saúde de rotina, exames especializados para doenças crónicas como diabetes, cancro e doenças cardiovasculares, bem como procedimentos de diagnóstico avançados. Envolve também a utilização de tecnologia e equipamento médico para realizar estes testes e inclui frequentemente programas de gestão da saúde destinados a promover o bem-estar geral e a intervenção precoce. O mercado dos exames de saúde é impulsionado pela crescente consciencialização pública sobre os cuidados preventivos, pelos avanços na tecnologia de diagnóstico e pela crescente procura por soluções de saúde personalizadas.
Dinâmica do mercado de rastreio de saúde da ASEAN
Esta secção trata da compreensão dos impulsionadores, oportunidades, restrições e desafios do mercado. Tudo isto é discutido em detalhe abaixo:
Motorista
- Aumento da população geriátrica
A crescente população geriátrica na região da ASEAN é um fator chave para o mercado de exames de saúde. Por exemplo, em 2020, 13,6 por cento da população da Ásia e do Pacífico tem 60 anos ou mais; O rastreio de saúde desempenha um papel crucial neste contexto, oferecendo exames de rotina, testes de diagnóstico e rastreios para diversas condições de saúde, como doenças cardiovasculares, cancro, diabetes e doenças respiratórias.
While longer lifespans reflect the region’s development success, comprehensive policy reforms are urgently needed to support the welfare of older people, according to Aging Well in Asia: Asian Development Policy Report, released by the Asian Development Bank (ADB) at its 57th Annual Meeting. The number of people aged 60 and older in developing Asia and the Pacific is set to nearly double by 2050 to 1.2 billion—or about a quarter of the total population—significantly increasing the need for pension and welfare programs as well as health care services.
The demand for health screening services is further bolstered by increasing healthcare expenditures, rising disposable incomes, and a growing understanding of the benefits of proactive healthcare management among the aging population in ASEAN. As a result, the health screening market in the region is expected to continue expanding to meet the needs of the increasing geriatric demographic.
Restraint
- High Cost of Healthcare Services
The high cost of health screening services presents a significant restraint for the ASEAN health screening market. Affordability remains a key concern, particularly in low- and middle-income countries where a large portion of the population struggle to access or afford comprehensive health screenings. This economic barrier limits the widespread adoption of preventive healthcare measures and early detection services, hindering efforts to combat the rising burden of chronic diseases in the region. Addressing the issue of high costs requires collaborative efforts from governments, healthcare providers, and private sector entities to develop cost-effective screening solutions, negotiate affordable pricing structures, and implement subsidies or insurance schemes to enhance accessibility for underserved populations.
Opportunity
- Technological Advancements in Health Screening
Innovations in imaging technology, molecular diagnostics, and digital health solutions have revolutionized how diseases are detected and monitored. Technologies such as PCR-based assays, high-resolution imaging techniques, and artificial intelligence-driven analytics have improved the accuracy, speed, and accessibility of health screening tests. This not only benefits healthcare providers by enabling earlier and more precise diagnoses but also empowers patients with better understanding and management of their health.
Moreover, the introduction of these advanced technologies has created a competitive environment where companies strive to differentiate themselves through innovation. These dynamic drives continuous improvement and the development of increasingly sophisticated screening tools, ultimately expanding the overall market for health screening products and services.
Challenge
- Inadequate Quality Assurance and Control
Variations in equipment calibration, maintenance, and operator training can lead to discrepancies in diagnostic accuracy and reliability. Inconsistent calibration schedules or lack of access to calibration services can result in inaccurate readings, affecting diagnosis and treatment outcomes. Additionally, inadequate maintenance due to budget constraints or lack of skilled technicians can cause equipment malfunctions, leading to downtime and unreliable diagnostic results. The proficiency of healthcare providers in operating diagnostic equipment and conducting screening procedures varies widely, and insufficient training along with the lack of standardized protocols can lead to human errors, further compromising the quality and reliability of screenings.
Recent Developments
- In August 2022, Fullerton Health completed merger led by RRJ Capital; Stronger Balance Sheet and New Corporate Structure propelled the post-pandemic growth opportunities. Fullerton Health Corporation Limited (“Fullerton Health” or the “Company”) announced that it had completed a merger led by RRJ Capital (“RRJ”) involving an equity injection by the private equity firm and a senior loan totalling USD 390 million. The merger delivered a stronger balance sheet and a new capital structure which propelled the post-pandemic growth opportunities for the pan-Asian healthcare provider
ASEAN Health Screening Market Scope
ASEAN health screening market is segmented into eight notable segments based on test type, application, panel type, care/facility, user, customer income, provider, country. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Test Type
- Cholesterol Tests
- Diabetes Test
- Cancer Tests
- General Check Up Test
- STD's
- Blood Pressure Test
- Others
On the basis of test type, the market is segmented into cholesterol tests, diabetes test, cancer tests, general check up test, STD's, blood pressure test, and others.
Application
- Cardiovascular Disease
- Metabolic Disorders
- Oncology
- Inflammatory Conditions
- Musculoskeletal Disorders
- Neurological Conditions
- Hepatitis-C Complications
- Immunology-Related Conditions
- Others
On the basis of application, the market is segmented into cardiovascular disease, metabolic disorders, oncology, inflammatory conditions, musculoskeletal disorders, neurological conditions, hepatitis-c complications, immunology-related conditions, and others.
Panel Type
- Multi-Test Panels
- Single-Test Panels
On the basis of panel type, the market is segmented into multi-test panels and single-test panels.
Care/Facility
- Integrated
- Standalone
On the basis of care/facility, the market is segmented into integrated and standalone.
User
- Domestic User
- Medical Tourist
On the basis of user, the market is segmented into domestic user and medical tourist.
Customer Income
- Upper Class
- Medium Class
- Lower Class
Com base no rendimento do cliente, o mercado está segmentado em classe alta, classe média e classe baixa.
Provedor
- Hospitais
- Clínicas
- Instalações de enfermagem
- Centros de Reabilitação
- Laboratórios de Diagnóstico
- Outros
Com base no fornecedor, o mercado está segmentado em hospitais, clínicas, enfermarias, centros de reabilitação, laboratórios de diagnóstico, entre outros.
Análise/perspetivas regionais do mercado de rastreio de saúde da ASEAN
O mercado de exames de saúde da ASEAN está segmentado em oito segmentos notáveis com base no tipo de teste, aplicação, tipo de painel, serviço/instalação, utilizador, rendimento do cliente, fornecedor e país.
Os países abrangidos neste relatório de mercado são a Índia, Singapura, Tailândia, Malásia, Indonésia, Filipinas, Vietname, Camboja, Brunei, Birmânia e Laos.
A secção de países do relatório também fornece fatores individuais que impactam o mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais e o impacto dos canais de vendas, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Análise do cenário competitivo e da quota de mercado de rastreio de saúde da ASEAN
O panorama competitivo do mercado de rastreio de saúde da ASEAN fornece detalhes dos concorrentes. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em I&D, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, aprovações de produtos, largura e amplitude do produto, domínio de aplicação e tipo de produto curva da linha de vida. Os dados fornecidos acima estão apenas relacionados com o foco da empresa no mercado.
Alguns dos principais players do mercado que operam no mercado são a Fullerton Health Corporation Limited, Mount Alvernia Hospital, Pt Prodia Widyahusada Tbk., Raffles Medical Group, Icon Group e The Farrer Park Company, entre outros.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASEAN HEALTH SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 ASEAN HEALTH SCREENING MARKET: REGULATIONS
5.1 REGULATIONS IN INDIA:
5.2 REGULATIONS IN SINGAPORE:
5.3 REGULATIONS IN THAILAND:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING GERIATRIC POPULATION
6.1.2 RISING NUMBER OF CHRONIC DISEASES
6.1.3 RISING AWARENESS AMONG PEOPLE FOR HEALTH SCREENING
6.2 RESTRAINTS
6.2.1 HIGH COST OF HEALTHCARE SERVICES
6.2.2 LACK OF TRAINED HEALTHCARE PROFESSIONALS
6.3 OPPORTUNITIES
6.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEALTH SCREENING
6.3.2 ACQUISITIONS AND MERGERS AMONG THE MARKET
6.3.3 NEW PRODUCT AND SERVICE LAUNCHES IN THE MARKET
6.4 CHALLENGES
6.4.1 INADEQUATE QUALITY ASSURANCE AND CONTROL
6.4.2 OPERATIONAL BARRIERS IN CONDUCTING SCREENING TESTS
7 ASEAN HEALTH SCREENING MARKET, BY TEST TYPE
7.1 OVERVIEW
7.2 CHOLESTEROL TESTS
7.2.1 TOTAL CHOLESTEROL TEST
7.2.2 TRIGLYCERIDES
7.2.3 LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL
7.2.4 HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL
7.3 DIABETES TEST
7.3.1 FASTING/RANDOM BLOOD SUGAR TEST
7.3.2 A1C TEST
7.3.3 GLUCOSE TOLERANCE TEST
7.4 CANCER TESTS
7.4.1 LIQUID BIOPSY
7.4.2 MAMMOGRAMS, OSTEOPOROSIS, BREAST MRI, AND PAP SMEAR TESTS
7.4.3 LOW-DOSE HELICAL COMPUTED TOMOGRAPHY
7.4.4 COLORECTAL CANCER SCREENING TEST (STOOL TESTS, SIGMOIDOSCOPY, COLONOSCOPY, BLOOD-BASED DNA TEST, DOUBLE-CONTRAST BARIUM ENEMA (DCBE), AND SINGLE-SPECIMEN GFOBT)
7.4.5 PROSTATE SPECIFIC ANTIGEN (PSA) TEST
7.4.6 NEW-EARLY DETECTION CANCER TESTS
7.4.7 ALPHA FETOPROTEIN BLOOD TEST
7.4.8 CA-125 TEST
7.4.9 OTHERS
7.5 GENERAL CHECK UP TEST
7.5.1 REGULAR CHECK UP
7.5.1.1 REGULAR BLOOD TEST
7.5.1.2 X-RAYS
7.5.1.3 ECG
7.5.1.4 FECALYSIS
7.5.1.5 URINALYSIS
7.5.1.6 BMI
7.5.1.7 OTHERS
7.5.2 EYE CHECK UP
7.5.3 DENTAL TEST
7.5.4 HEARING TEST
7.6 STD'S
7.6.1 CHLAMYDIA
7.6.2 GONORRHEA
7.6.3 HPV
7.6.4 HIV
7.6.5 OTHERS
7.7 BLOOD PRESSURE TEST
7.8 OTHERS
7.8.1 LIVER FUNCTION TESTS
7.8.2 KIDNEY PROFILE
8 ASEAN HEALTH SCREENING MARKET, BY PANEL TYPE
8.1 OVERVIEW
8.2 MULTI-TEST PANELS
8.3 SINGLE-TEST PANELS
9 ASEAN HEALTH SCREENING MARKET, BY CARE/FACILITY
9.1 OVERVIEW
9.2 INTEGRATED
9.3 STANDALONE
10 ASEAN HEALTH SCREENING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 CARDIOVASCULAR DISEASE
10.2.1 CORONARY HEART DISEASE
10.2.2 ATHEROSCLEROSIS
10.3 METABOLIC DISORDERS
10.3.1 DIABETES MELLITUS
10.3.2 OBESITY
10.4 ONCOLOGY
10.5 INFLAMMATORY CONDITIONS
10.5.1 AUTOIMMUNE CONDITIONS
10.5.2 ALLERGIES
10.5.3 ARTHRITIS
10.5.4 ASTHMA
10.5.5 INFLAMMATORY DIGESTIVE PROBLEMS
10.6 MUSCULOSKELETAL DISORDERS
10.6.1 OSTEOPOROSIS
10.6.2 RHEUMATOID ARTHRITIS
10.7 NEUROLOGICAL CONDITIONS
10.7.1 CHRONIC STRESS
10.7.2 ALZHEIMER'S DISEASE
11 ASEAN HEALTH SCREENING MARKET, BY CUSTOMER INCOME
11.1 OVERVIEW
11.2 UPPER CLASS
11.3 MEDIUM CLASS
11.4 LOWER CLASS
12 ASEAN HEALTH SCREENING MARKET, BY PROVIDER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 CLINICS
12.4 NURSING FACILITIES
12.5 REHABILITATION CENTERS
12.6 DIAGNOSTIC LABORATORIES
12.7 OTHERS
13 ASEAN HEALTH SCREENING MARKET, BY USER
13.1 OVERVIEW
13.2 DOMESTIC USER
13.3 MEDICAL TOURIST
14 ASEAN HEALTH SCREENING MARKET, BY COUNTRY
14.1 INDIA
14.2 SINGAPORE
14.3 THAILAND
14.4 MALAYSIA
14.5 INDONESIA
14.6 PHILIPPINES
14.7 VIETNAM
14.8 CAMBODIA
14.9 BRUNEI
14.1 BURMA
14.11 LAOS
15 ASEAN MEDICAL SCREENING MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
16 SWOT ANALYSIS
17 COMPANY PROFILES
17.1 FULLERTON HEALTH CORPORATION LIMITED.
17.1.1 COMPANY SNAPSHOT
17.1.2 PRODUCT PORTFOLIO
17.1.3 RECENT DEVELOPMENT
17.2 MOUNT ALVERNIA HOSPITAL.
17.2.1 COMPANY SNAPSHOT
17.2.2 PRODUCT PORTFOLIO
17.2.3 RECENT DEVELOPMENT
17.3 PT PRODIA WIDYAHUSADA TBK.
17.3.1 COMPANY SNAPSHOT
17.3.2 PRODUCT PORTFOLIO
17.3.3 RECENT DEVELOPMENT
17.4 RAFFLES MEDICAL GROUP
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENT
17.5 ICON GROUP
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.6 THE FARRER PARK COMPANY
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 PT SILOAM INTERNATIONAL HOSPITALS TBK.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 SINGHEALTH GROUP
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 IHH HEALTHCARE BERHAD
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 LIFESCAN MEDICAL & WELLNESS (A SUBSIDIARY OF SINGAPORE MEDICAL GROUP LIMITED)
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 MANADR PTE LTD.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 NATIONAL UNIVERSITY HEALTH SYSTEM.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 PT MEDIKA LOKA MANAJEMEN
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 ROYAL HEALTHCARE
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 ROYAL PHNOM PENH HOSPITAL
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 KALBE
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
Lista de Tabela
TABLE 1 ASEAN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 2 ASEAN CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 3 ASEAN DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 4 ASEAN CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 5 ASEAN GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 6 ASEAN REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 7 ASEAN STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 8 ASEAN OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 9 ASEAN HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 10 ASEAN HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)..
TABLE 11 ASEAN HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 12 ASEAN CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 13 ASEAN METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 14 ASEAN INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 15 ASEAN MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 16 ASEAN NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 17 ASEAN HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 18 ASEAN HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 19 ASEAN HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 20 ASEAN HEALTH SCREENING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 21 INDIA HEALTH SCREENING MARKET, BY CITY, 2022-2031 (USD MILLION)
TABLE 22 INDIA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 23 INDIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 24 INDIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 25 INDIA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 26 INDIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 27 INDIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 28 INDIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 29 INDIA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 30 INDIA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 31 INDIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 32 INDIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 33 INDIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 34 INDIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 35 INDIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 36 INDIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 37 INDIA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 38 INDIA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 39 INDIA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 40 INDIA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 41 SINGAPORE HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)..
TABLE 42 SINGAPORE CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 43 SINGAPORE DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 44 SINGAPORE CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 45 SINGAPORE GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 46 SINGAPORE REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 47 SINGAPORE STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 48 SINGAPORE OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 49 SINGAPORE HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 50 SINGAPORE CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 51 SINGAPORE METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 52 SINGAPORE INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 53 SINGAPORE MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 54 SINGAPORE NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 55 SINGAPORE HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 56 SINGAPORE HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 57 SINGAPORE HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 58 SINGAPORE HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 59 SINGAPORE HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)..
TABLE 60 THAILAND HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 61 THAILAND CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 62 THAILAND DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 63 THAILAND CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 64 THAILAND GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 65 THAILAND REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 66 THAILAND STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 67 THAILAND OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 68 THAILAND HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 69 THAILAND CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 70 THAILAND METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 71 THAILAND INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 72 THAILAND MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 73 THAILAND NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 74 THAILAND HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)..
TABLE 75 THAILAND HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 76 THAILAND HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 77 THAILAND HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 78 THAILAND HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 79 MALAYSIA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 80 MALAYSIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 81 MALAYSIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 82 MALAYSIA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 83 MALAYSIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 84 MALAYSIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 85 MALAYSIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 86 MALAYSIA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 87 MALAYSIA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 88 MALAYSIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 89 MALAYSIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 90 MALAYSIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 91 MALAYSIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 92 MALAYSIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 93 MALAYSIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)..
TABLE 94 MALAYSIA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 95 MALAYSIA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 96 MALAYSIA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 97 MALAYSIA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 98 INDONESIA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)…
TABLE 99 INDONESIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 100 INDONESIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 101 INDONESIA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 102 INDONESIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 103 INDONESIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 104 INDONESIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 105 INDONESIA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 106 INDONESIA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 107 INDONESIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 108 INDONESIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 109 INDONESIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 110 INDONESIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 111 INDONESIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 112 INDONESIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 113 INDONESIA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 114 INDONESIA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 115 INDONESIA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 116 INDONESIA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)..
TABLE 117 PHILIPPINES HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 118 PHILIPPINES CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 119 PHILIPPINES DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 120 PHILIPPINES CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 121 PHILIPPINES GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 122 PHILIPPINES REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 123 PHILIPPINES STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 124 PHILIPPINES OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 125 PHILIPPINES HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 126 PHILIPPINES CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 127 PHILIPPINES METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 128 PHILIPPINES INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 129 PHILIPPINES MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 130 PHILIPPINES NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 131 PHILIPPINES HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 132 PHILIPPINES HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 133 PHILIPPINES HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 134 PHILIPPINES HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 135 PHILIPPINES HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 136 VIETNAM HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 137 VIETNAM CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 138 VIETNAM DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 139 VIETNAM CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 140 VIETNAM GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 141 VIETNAM REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 142 VIETNAM STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 143 VIETNAM OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 144 VIETNAM HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)..
TABLE 145 VIETNAM CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 146 VIETNAM METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 147 VIETNAM INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 148 VIETNAM MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 149 VIETNAM NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 150 VIETNAM HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 151 VIETNAM HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 152 VIETNAM HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 153 VIETNAM HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 154 VIETNAM HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 155 CAMBODIA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)…
TABLE 156 CAMBODIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 157 CAMBODIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 158 CAMBODIA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 159 CAMBODIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 160 CAMBODIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 161 CAMBODIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 162 CAMBODIA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 163 CAMBODIA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 164 CAMBODIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 165 CAMBODIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 166 CAMBODIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 167 CAMBODIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 168 CAMBODIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 169 CAMBODIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 170 CAMBODIA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 171 CAMBODIA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 172 CAMBODIA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 173 CAMBODIA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)..
TABLE 174 BRUNEI HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 175 BRUNEI CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 176 BRUNEI DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 177 BRUNEI CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 178 BRUNEI GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 179 BRUNEI REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 180 BRUNEI STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 181 BRUNEI OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 182 BRUNEI HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 183 BRUNEI CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 184 BRUNEI METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 185 BRUNEI INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 186 BRUNEI MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 187 BRUNEI NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 188 BRUNEI HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 189 BRUNEI HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 190 BRUNEI HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 191 BRUNEI HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 192 BRUNEI HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 193 BURMA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 194 BURMA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 195 BURMA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 196 BURMA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 197 BURMA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 198 BURMA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 199 BURMA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 200 BURMA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 201 BURMA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 202 BURMA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 203 BURMA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 204 BURMA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 205 BURMA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 206 BURMA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 207 BURMA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 208 BURMA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 209 BURMA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 210 BURMA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 211 BURMA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 212 LAOS HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 213 LAOS CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 214 LAOS DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 215 LAOS CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 216 LAOS GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 217 LAOS REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 218 LAOS STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 219 LAOS OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 220 LAOS HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 221 LAOS CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 222 LAOS METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 223 LAOS INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 224 LAOS MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 225 LAOS NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 226 LAOS HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 227 LAOS HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 228 LAOS HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 229 LAOS HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 230 LAOS HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
Lista de Figura
FIGURE 1 ASEAN HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 2 ASEAN HEALTH SCREENING MARKET: DATA TRIANGULATION
FIGURE 3 ASEAN HEALTH SCREENING MARKET: DROC ANALYSIS
FIGURE 4 ASEAN HEALTH SCREENING MARKET: REGIONAL MARKET ANALYSIS
FIGURE 5 ASEAN HEALTH SCREENING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASEAN HEALTH SCREENING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASEAN HEALTH SCREENING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 ASEAN HEALTH SCREENING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASEAN HEALTH SCREENING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASEAN HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 11 SEVEN SEGMENTS COMPRISE THE ASEAN HEALTH SCREENING MARKET, BY TEST TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DEVELOPMENTS
FIGURE 14 RISING NUMBER OF CHRONIC DISEASES IS DRIVING THE GROWTH OF THE ASEAN HEALTH SCREENING MARKET FROM 2024 TO 2031
FIGURE 15 THE CHOLESTEROL TESTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASEAN HEALTH SCREENING MARKET IN 2024 AND 2031
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASEAN HEALTH SCREENING MARKET
FIGURE 17 ASEAN HEALTH SCREENING MARKET: BY TEST TYPE, 2023
FIGURE 18 ASEAN HEALTH SCREENING MARKET: BY TEST TYPE, 2024-2031 (USD MILLION)
FIGURE 19 ASEAN HEALTH SCREENING MARKET: BY TEST TYPE, CAGR (2024-2031)
FIGURE 20 ASEAN HEALTH SCREENING MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 21 ASEAN HEALTH SCREENING MARKET: BY PANEL TYPE, 2023
FIGURE 22 ASEAN HEALTH SCREENING MARKET: BY PANEL TYPE, 2024-2031 (USD MILLION)
FIGURE 23 ASEAN HEALTH SCREENING MARKET: BY PANEL TYPE, CAGR (2024-2031)
FIGURE 24 ASEAN HEALTH SCREENING MARKET: BY PANEL TYPE, LIFELINE CURVE
FIGURE 25 ASEAN HEALTH SCREENING MARKET: BY CARE/FACILITY, 2023
FIGURE 26 ASEAN HEALTH SCREENING MARKET: BY CARE/FACILITY, 2024-2031 (USD MILLION)
FIGURE 27 ASEAN HEALTH SCREENING MARKET: BY CARE/FACILITY, CAGR (2024-2031)
FIGURE 28 ASEAN HEALTH SCREENING MARKET: BY CARE/FACILITY, LIFELINE CURVE
FIGURE 29 ASEAN HEALTH SCREENING MARKET: BY APPLICATION, 2023
FIGURE 30 ASEAN HEALTH SCREENING MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 31 ASEAN HEALTH SCREENING MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 32 ASEAN HEALTH SCREENING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 33 ASEAN HEALTH SCREENING MARKET: BY CUSTOMER INCOME, 2023
FIGURE 34 ASEAN HEALTH SCREENING MARKET: BY CUSTOMER INCOME, 2024-2031 (USD MILLION)
FIGURE 35 ASEAN HEALTH SCREENING MARKET: BY CUSTOMER INCOME, CAGR (2024-2031)
FIGURE 36 ASEAN HEALTH SCREENING MARKET: BY CUSTOMER INCOME, LIFELINE CURVE
FIGURE 37 ASEAN HEALTH SCREENING MARKET: BY PROVIDER, 2023
FIGURE 38 ASEAN HEALTH SCREENING MARKET: BY PROVIDER, 2024-2031 (USD MILLION)
FIGURE 39 ASEAN HEALTH SCREENING MARKET: BY PROVIDER, CAGR (2024-2031)
FIGURE 40 ASEAN HEALTH SCREENING MARKET: BY PROVIDER, LIFELINE CURVE
FIGURE 41 ASEAN HEALTH SCREENING MARKET: BY USER, 2023
FIGURE 42 ASEAN HEALTH SCREENING MARKET: BY USER, 2024-2031 (USD MILLION)
FIGURE 43 ASEAN HEALTH SCREENING MARKET: BY USER, CAGR (2024-2031)
FIGURE 44 ASEAN HEALTH SCREENING MARKET: BY USER, LIFELINE CURVE
FIGURE 45 ASEAN HEALTH SCREENING MARKET: SNAPSHOT, 2023
FIGURE 46 ASEAN MEDICAL SCREENING MARKET: COMPANY SHARE 2023 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
